Article info
PDFEAHP congress previews
Changes in development and evaluation of new cancer drugs: what is needed to guide practice?
- Correspondence to Wolf-Dieter Ludwig, HELIOS Clinic Berlin-Buch, Department of Hematology, Oncology and Tumor Immunology, Drug Commission of the German Medical Association, Schwanebecker Chaussee 50, 13125 Berlin, Germany; wolf-dieter.ludwig{at}helios-kliniken.de
Citation
Changes in development and evaluation of new cancer drugs: what is needed to guide practice?
Publication history
- Accepted January 25, 2012
- First published March 12, 2012.
Online issue publication
May 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions